The scope of the BNF is restricted to the discussion of conventional medicines but reference is made to complementary treatments if they affect conventional therapy (e. Where an unlicensed drug is included in the BNF, this is indicated in the unlicensed use section of the drug monograph.

This carries the advantage of providing all of the information in one place, so the user does not need to flick back and forth across several pages to find all of the relevant information for that drug.Monograph titles follow the convention of recommended international non-proprietary names (rINNs), or, in the absence of a rINN, British Approved Names. addition of Southeast Asian ethnicity to dosing for treatment of chronic idiopathic thrombocytopenic purpura and aplastic anaemia].

Level 2+ Well-conducted case control or cohort studies with a low risk of confounding or bias and a moderate probability that the relationship is causal. The Treatment Summaries provide guidance on the drug treatment of common conditions that can occur during pregnancy or breast-feeding (e.Drugs and driving Prescribers and other healthcare professionals should advise patients if treatment is likely to affect their ability to perform skilled tasks (e. We encourage healthcare professionals to regularly review the prescribing information on drugs that they encounter frequently; .

updated guidance for immunisation of neonates and adults aged 70-79 years inline with Public Health England/UK Health Security Agency recommendations. The addition of evidence grading is to support clinical decision-making based on the best available evidence. The book cover has no visible wear, and the dust jacket (if applicable) is included for hard covers.

Use of drugs in specific patient populations Drug selection should aim to minimise the potential for drug accumulation, adverse drug reactions, and exacerbation of pre-existing hepatic or renal disease.